We propose that the reduced phosphorylation of
Smad3 that we observed after rAAV6:Fst-288 administration
(owing to Fst inhibiting the actions of TGF- family members
that otherwise promote phosphorylation of Smad3) will
directly impact upon the transcription of TGF- target genes
that influence protein synthesis and degradation in skeletal
muscle